An Exploratory Randomized, 2-Part, Single-blind, 2-Period Crossover Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2017
At a glance
- Drugs Albiglutide (Primary) ; Exenatide
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 12 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Apr 2017 Planned End Date changed from 1 Jun 2018 to 29 Sep 2017.
- 14 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 29 Sep 2017.